Life Science Nation Newsletter  | January 5,  2017  |  Issue 195

  The LSN Story   |   Investor Platform   |   Company Platform   |   RESI Conference   |   Fundraising Consulting
Life Science Investor Mandates (Dec. 29  - Jan. 4)
Invests in Disruptive Medical Devices
Partnering on Transformational Therapeutic Assets in Any Indication Area
Invests Evergreen Fund in Therapeutics, Devices, and Diagnostics
Invests in Clinical Stage Biopharmaceuticals, Devices and Diagnostics for China Market
In This Issue
Nature BioEntrepreneur Features LSN: Aligning Needs
LSN Services
Click to see investors that are a fit for your product and stage of development

Click here if you are a service provider and want to see a list of funded life science companies that are a fit for you

Click here if you want to receive free, targeted early stage dealflow for your life science investment firm

LSN Book

LSN Videos
RESI Boston Investors Panel

By Nono Hu, Director of Marketing, LSN